Skip to content

Clinical trials

Coronavirus Infections trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Country / region: India Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20207
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Bharat Biotech International Limited1
Eli Lilly and Company1
GlaxoSmithKline1
Kirby Institute1
Level 42 AI, Inc.1
MGC Pharmaceuticals d.o.o1
PUNEET MITTAL1
Population Health Research Institute1
The Herb, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections10
COVID-199
Severe Acute Respiratory Syndrome3
Acquired Immunodeficiency Syndrome1
Infections1
Influenza, Human1
Lung Diseases1
Respiratory Distress Syndrome1
Respiratory Tract Infections1
Thrombosis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.